rATG is a polyclonal anti–T-cell IgG that binds multiple T-cell antigens (e.g., CD2/CD3/CD4/CD8) and depletes T cells via complement-dependent cytotoxicity, ADCC, and apoptosis; it is not directed against CD44, so CD44+ cells are not directly killed.